RxDoctor Payments DataLook up a doctor →

Anna Parchman, MD

Family Medicine · Hot Springs, ARNPI 1578565321

Payments from drug & device makers

$27,802in general payments, 2019–2025

Across 964 payments — averaging $28.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$12K
  • AbbVie$5K
  • Amgen$2K
  • Pfizer$898
  • Johnson & Johnson$792
  • GSK$716
  • plus $7K from 50 others

What the payments were for

  • Travel & lodging$780%
  • Food & beverage$17,795100%
  • Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca94$11,829
AbbVie(2 entities)266$4,696
Amgen(2 entities)84$1,768
Pfizer74$898
Johnson & Johnson32$792
GSK41$716
Otsuka America Pharmaceutical, Inc.29$716
Lilly USA, LLC55$691
Sunovion Pharmaceuticals Inc.25$391
Bayer14$320
Antares Pharma, Inc.12$318
Gilead12$309
Novartis17$307
Genentech USA, Inc.4$304
Abbott17$274
Biohaven Pharmaceuticals, Inc.11$259
Amarin Pharma, Inc.12$224
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)13$219
Axsome Therapeutics, Inc.10$216
Novo Nordisk14$206
Takeda Pharmaceuticals U.S.A., Inc.13$206
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC13$204
Dexcom, Inc.10$171
Sumitomo Pharma America, Inc.12$160
Procept Biorobotics Corporation1$156
Actelion Pharmaceuticals US, Inc.2$145
Merck8$117
Supernus Pharmaceuticals, Inc.5$101
Astellas Pharma US Inc6$97
Urovant Sciences Inc1$78
Ironwood Pharmaceuticals, Inc6$78
Teva Pharmaceuticals USA, Inc.5$77
Boehringer Ingelheim5$71
Kowa Pharmaceuticals America, Inc.5$67
Esperion Therapeutics, Inc.5$65
Nestle Healthcare Nutrition Inc.3$62
Radius Health, Inc.3$60
Corium, LLC2$44
Bausch Health US, LLC2$42
Biohaven Pharmaceutical Holding Company Ltd.2$39
Lundbeck LLC2$34
Eisai Inc.2$29
Exact Sciences2$29
Pacira Therapeutics, Inc.1$28
Redhill Biopharma Inc.1$21
Neurocrine Biosciences, Inc.1$20
Verona Pharma, Inc.1$18
Revance Therapeutics, Inc.1$18
Avanir Pharmaceuticals, Inc.1$17
Upsher-smith Laboratories LLC1$16
Shire North American Group Inc1$15
Vanda Pharmaceuticals Inc.1$15
Bardy Diagnostics, Inc.1$15
Zyla Life Sciences, Inc.1$14
Xeris Pharmaceuticals, Inc.1$14
Sanofi-aventis U.S. LLC1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$27,802 in reported general payments places this provider in the 95th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$271,501
Medicare patients
528
Services billed
14,698

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide191$212,928
OzempicSemaglutide64$82,737
FarxigaDapagliflozin Propanediol81$68,201
JardianceEmpagliflozin56$52,148
Soliqua 100-33Insulin Glargine/Lixisenatide29$20,011
EliquisApixaban21$19,446
JanuviaSitagliptin Phosphate15$15,401
TrulicityDulaglutide15$14,958
GemtesaVibegron14$10,772
JanumetSitagliptin Phos/Metformin Hcl12$7,060
JentaduetoLinagliptin/Metformin Hcl12$6,342
Breo ElliptaFluticasone/Vilanterol12$5,203
LivaloPitavastatin Calcium12$4,096
Duloxetine Hcl110$3,481
Levothyroxine Sodium299$2,303

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$691$227,886206 claims
Novo NordiskOzempic$206$82,73764 claims
AstraZenecaFarxiga$11,829$68,20181 claims
Boehringer IngelheimJardiance, Jentadueto$71$58,49068 claims
MerckJanuvia, Janumet$117$22,46127 claims
PfizerEliquis, Dilantin$898$21,29233 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$11$20,01129 claims
Sumitomo Pharma America, Inc.Gemtesa$160$10,77214 claims
GSKBreo Ellipta$716$5,20312 claims
Kowa Pharmaceuticals America, Inc.Livalo$67$4,09612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in Hot Springs

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →